Oxyphenbutazone
Back to searchMolecule Structure
Scientific Name
Oxyphenbutazone
Description of the Drug
Oxyphenbutazone is a nonsteroidal anti-inflammatory drug (NSAID) no longer commonly used for the symptomatic relief of musculoskeletal pain.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB03585
http://www.drugbank.ca/drugs/DB03585
Brand Name(s)
Oxyphenbutazone, Tandearil
Company Owner(s)
Watson Laboratories Inc, Novartis Pharmaceuticals Corp
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Cyclooxygenase | PROTEIN FAMILY | INHIBITOR | CHEMBL2094253 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL25857 | |
| PharmGKB | PA450750 | |
| Human Metabolome Database | HMDB0256021 | |
| DrugBank | DB03585 | |
| PubChem: Thomson Pharma | 14874898 | |
| PubChem | 4641 | |
| Mcule | MCULE-3785704527 | |
| LINCS | LSM-5029 | |
| Nikkaji | J10.648H | |
| BindingDB | 200298 | |
| EPA CompTox Dashboard | DTXSID1045291 | |
| DrugCentral | 2036 | |
| Metabolights | MTBLC76258 | |
| Brenda | 94576 | 165883 |
| ChemicalBook | CB2133346 | |
| rxnorm | OXYPHENBUTAZONE | |
| KEGG Ligand | C19494 | |
| ChEBI | 76258 |
